Bio-fluids contain various circulating cell-free RNA transcripts (ccfRNAs). The composition of 20 these ccfRNAs varies between bio-fluids and constitute tantalizing biomarker candidates for 21 several pathologies. ccfRNAs have also been demonstrated as mediators of cellular 22 communication, yet little is known about their function in physiological and developmental 23 settings and most works are limited to in-vitro studies. Here, we have developed iTAG-RNA, a 24 novel method for the unbiased tagging of RNA transcripts in mice in-vivo. We used this method 25 to isolate hepatocytes and kidney proximal epithelial cells-specific transcriptional response to a 26 dietary challenge without interfering with the tissue architecture, and to identify multiple 27 hepatocyte-secreted ccfRNAs in plasma. We also identified transfer of these hepatic derived 28 ccfRNAs to adipose tissue, where they likely serve as a buffering mechanism to maintain 29 cholesterol and lipid homeostasis. Our findings directly demonstrate in-vivo transfer of RNAs 30 between tissues and highlight its implications for endocrine signaling and homeostasis.
Introduction
Small molecule design and genetic approach for targeted in-vivo labeling of RNA 93 5-Ethynyl Uridine (5EU) is a synthetic uridine analogue extensively used in RNA turnover studies 94 [27] [28] [29] . The nitrogenous base contains an alkyne group that can be covalently linked to an azide 95 group using a simple copper mediated reaction called click chemistry [30, 31] . This synthetic base 96 has been demonstrated to incorporate into transcribing RNA in place of uridine and have little to 97 no biological effects thereafter [27] . Following administration to mice, 5EU is readily taken up by 98 cells with no regard to cell identity, depending to some extent on the administration method and 99 dosage used [27] . Here, we present a novel method for the targeted in-vivo delivery of 5EU. 100 To achieve this, we designed a 'pro-drug' of the 5EU base (HD5EU) that is based on the 'Hep-101 Direct' pro-drug design [32, 33] (Figure 1a ). This design was developed to target small molecules 102 and nucleotide analogues to the human CYP3A4 enzyme and several small molecules of this 103 design have been or are currently in clinical studies [34] [35] [36] . The human CYP3A4 enzyme 104 catalyzes an oxidative cleavage of the HD5EU small molecule which, following a spontaneous 105 beta-elimination, results in the formation of 5EU mono-phosphate that can then be incorporated 106 into transcribing RNA (Figure 1a ). HD5EU was synthesized by Chiroblock GmbH, the identity 107 of the final product was validated using MS, p-NMR and h-NMR and the molecule's purity was 108 assessed at over 98% (Sup. Figure 1a-d) . 109 In addition to the HD5EU small molecule we took advantage of the published humanized liver CYP3A4 is necessary for in-vitro and in-vivo metabolism of the HD5EU small molecule 143 To test and validate the metabolism of the HD5EU small molecule, we first isolated primary 144 hepatocytes from hCYP3A4 mice. Following an 8 hour treatment of primary hepatocytes with 145 1mM HD5EU or 5EU, nuclear staining similar to 5EU labeling is clearly evident following click-146 it fluorescent staining (Figure 2a) . When pre-treated with Azamulin, a highly selective CYP3A4 147 inhibitor [40] , HD5EU treated primary hepatocytes no longer demonstrate nuclear staining, in 148 contrast to 5EU treated primary hepatocytes, where nuclear staining is unaffected by Azamulin 149 pretreatment (Figure 2a) . These results indicate that while 5EU is still readily incorporated into 150 transcribing RNA in the nucleus, nuclear staining in HD5EU treated cells is dependent upon 151 CYP3A4 activity. 152 We administered HD5EU to humanized CYP3A4 mice and already 2 hours following 
Mass-Spectrometric validation and quantification of 5EU incorporation into RNA following

175
HD5EU treatment 176 To validate that nuclear staining evident in-vitro and in-vivo following HD5EU treatment is indeed 177 indicative of 5EU incorporation into transcribing RNA, we adopted the mass-spectrometry method 178 described by Su et. al [41] . Using a column with a smaller inner diameter and lower flow rates to 179 improve the response of individual nucleotides, we were able to identify a wide range of 180 unmodified and modified nucleotides (Sup. 
185
Tandem mass spectrometry validated that 5EU is present in RNA extracted from the liver of 186 HD5EU treated mice (Figure 3a-d) . The main fragment at 20eV collision energy was the neutral Figure 2a ). In-vivo, we could detect and 194 quantify 5EU incorporation into both short (less than 200bp) and long RNA isolated from the liver 195 of HD5EU treated mice, 2 hours following the administration of the compound (Figure 3f-g) . 8h 196 following HD5EU administration 5EU was still detectable in long RNA (though it could not be 197 accurately quantified as it was below quantification limit), whilst only a moderate reduction was 198 detected in short RNA.
199
Taken together, these results confirm that HD5EU is metabolized in a CYP3A4 dependent manner 200 to 5EU, which is then incorporated into transcribing RNA. Azamulin treatment inhibits CYP3A4 mediated HD5EU metabolism to 5EUMP and its subsequent 211 incorporation into RNA. F) Bioanalyzer image depicting isolation of liver long and short RNA. Robustness and reproducibility of RNA precipitation. 217 2 hours following administration of HD5EU, 5EU-containing liver and kidney transcripts can be 218 biotinylated and pulled-down for next generation sequencing. We persistently failed to generate 219 any amplified libraries following pull-down of unlabeled RNA isolated from liver, plasma or kidney of saline treated control mice (Sup. Figure 3a-e ). In addition, following a 2 hour treatment 221 with HD5EU we failed to generate libraries following biotinylation and pull-down from plasma 222 and from additional tissues of the HD5EU-treated mice, this in contrast to liver and kidney where 223 expected library amplicons were generated (Sup. Figure 3a Figure 3f , spearman correlation coefficient = 0.95).
228
To further assess the levels of non-specific RNA pull-down, we prepared a 10:1 mixture of non-229 labeled small RNAs from S. Cerevisiae with labeled small RNAs derived from mouse liver. reprogramming. 237 We continued to examine if in-vivo labeling enriches for transcriptional programs of specific 238 cellular populations within complex tissues in-vivo, such as the proximal renal epithelial cells in 239 the kidney and hepatocytes in liver, and whether detection of environmentally induced 240 transcriptional reprogramming is possible. To this end we fed mice with high fat (HFD) or control 241 low fat (LFD) diets for two weeks. Following this acute HFD exposure, which is expected to alter 242 the transcriptional program in the liver [42], we administered HD5EU 2 hours before sacrificing. 243 We then continued to generate poly-A RNA libraries from kidney and liver input and pull-down 244 RNA.
245
Following mapping with the STAR aligner [43], transcript quantification using HTSeq-count and 246 differential pull-down analyses using the NOISeq package [44], we defined pulled-down 247 transcripts as those whose abundance can be estimated with a high degree of confidence to be at In kidney, where proximal renal epithelial cells are labelled, GO annotation and gene set 251 enrichment analysis using Enrichr [45] demonstrated an enrichment for genes localized to the 252 brush boarder membrane, along with a few more general terms found enriched also in input such 253 as mitochondria, focal adhesion and genes specific to or highly expressed in the kidney ( Figure   254 4b-c, Sup. table 3). The brush boarder membrane in the kidney is a unique feature of proximal 255 renal epithelial cells [46] , and among pulled-down transcripts, the Solute Carrier Family 9 member 256 A3 (Slc9a3) is one of its specific markers. Slc9a3 is the sodium-hydrogen antiporter 3, which is 257 highly expressed in the proximal tubule and allows active transport of sodium to the cell. Terms 258 uniquely enriched in genes depleted following pull-down include genes associated with ribosomal 259 function, genes specific to or highly expressed in CD34 positive cells, dendritic cells as well as 260 genes associated to neutrophil ficolin granules. CD34 positive cells are likely endothelial cells 261 found in glomeruli and blood vessels in both human and mice but absent from tubules [47, 48] .
262
In liver, enrichment for identified liver targets of the nuclear receptors PPARA, LXR and RXR is the top ranking genes defined in each study to be cluster specific markers to our pull-down 274 enrichment results. In kidney, we find the majority of cluster markers to be depleted following 275 pull-down of kidney poly-A RNA, apart from a small subset of markers for proximal tubule cells 276 (Figure 4f ). In liver, this trend continued and from the list of cluster specific markers, 80% of Taken together these results support specific labelling of renal proximal tubule epithelial cells in 280 the kidney and of hepatocytes in the liver, with enrichment of their transcriptomes in pulled-down 281 RNA and specific depletion for genes associated with other cell types found in these organs.
282
To assess the feasibility of detecting dynamic transcriptional responses using iTag-RNA, we Table 7) . 294 As opposed to liver, diet-induced differential expression in the kidney was limited to 108 Taken together, these results provide a proof-of-concept that iTAG-RNA allows isolation of cell-300 type specific transcriptional responses to environmental challenges. Importantly, with no need for 301 the disruption of the tissue architecture or interference with the cellular microenvironment. are predominantly short / fragmented RNA transcripts with a bi-modal distribution and a major 341 peak smaller than 200bp ([56] and sup figure 3g). As already described, with a single dose of 342 HD5EU 2 hours before blood collection we failed to generate libraries from plasma ccfRNA 343 following biotinylation and pull-down. However, with multiple doses of HD5EU administration 344 6, 4 and 2 hours before blood collection, we were able to generate small RNA libraries following (Figure 5c ). This result suggests that the majority of mitochondrial transcripts 357 found in plasma originate predominantly in the liver.
358
Additional support in favor of the hepatic origin of plasma labeled transcripts can be found in 359 fragments originating from protein coding genes. These protein coding fragments demonstrate a 360 significant enrichment for liver specific and highly expressed genes, whilst transcripts 361 constitutively depleted in pull-down RNA demonstrate an enrichment for bone marrow specific 362 protein coding fragments, genes related to hematopoietic differentiation and genes specific to 363 neutrophil function. (Figure 5d and sup. table 11) . This result may suggests that the 364 hematopoietic system is one of the major contributors of circulating RNAs. HFD and LFD specific 365 pulled-down protein coding transcripts demonstrate differential enrichment for annotations 366 including adipocytokine signaling and mitochondrial electron transport respectively (Figure 5e) . 367 The significant enrichment found for liver specific protein coding genes among pulled-down 368 transcripts supports the hypothesis that pulled-down ccfRNA transcripts originate in hepatocytes, 369 where Cyp3a4 expression metabolizes HD5EU to 5EU, allowing its incorporation into nascent 370 transcribing RNA. 
403
The number of transcripts found to be enriched following pull-down in liver, plasma and VsWAT 404 was 9.7 folds greater than expected by chance for HFD and 6.8 folds greater than expected for Figure 6a Sup tables 8-10) . Focusing on identified hepatic 407 transcribed plasma ccfRNAs, multiple small RNAs could be enriched for in VsWAT. These 408 include miRNAs such as mir-33, mir-10b and mir-130a, in addition to mt-tRNAs (Figure 6b) . 409 Among experimentally validated targets of the identified miRNAs (as annotated by miRTarBase 410 [66]), an enrichment is found for proteins associated with the GO term negative regulation of lipid 411 storage (GO:0010888, adj. P.V. = 0.0078, enrichment score = 26.68) such as Abca1, Ppara and 412 Pparg which are regulated by mir-33 [23, 24] , mir-10b [25] and mir-130a [26, 67] respectively.
413
Mir-33 is also an identified regulator of the Srebp family of transcription factors that are central 414 in cholesterol and fatty acid synthesis [68, 69] and is in fact encoded within the intron of Srebf2.
415
Total RNA sequencing of VsWAT identified 100 genes to be differentially expressed following 416 acute HFD feeding (28 upregulated / 72 downregulated, Sup table 12). As expected given the 417 increased dietary intake of free fatty acids following HFD feeding, downregulation of Srebf1 and 418 of several target genes involved in fatty acid biosynthesis such as FasN, Acaca, and Scd2 is evident 419 (Figure 6c-d) . To explore these two possibilities, we looked at the expression levels in VsWAT of the identified 426 miRNAs. Paradoxically, both small RNA-Seq and qRT-PCR (Fig.6e ) confirmed that rather than 427 upregulation of these miRNAs in VsWAT following HFD, no change or a moderate 428 downregulation in their levels is evident. This result most likely reflects a HFD-induced 429 downregulation of the endogenously transcribed adipocyte miRNAs and suggests that the transfer 430 of exogenous hepatic derived miRNAs buffers the downregulation of the adipocyte transcribed 431 miRNAs. Indeed upon acute HFD feeding and in keeping with mir-130a downregulation and 432 published results, Pparg protein but not transcript levels are modestly upregulated (Figure 6d, f) . 433 All together, these results showfor the first timetransfer of regulatory RNAs from hepatocytes In this work we present iTAG-RNA, a novel method for targeted in-vivo labelling of global RNA 452 transcription, and use it to identify hepatocyte secreted ccfRNA and their uptake by adipose tissue 453 in-vivo. iTAG-RNA allows labelling of total RNA transcripts in-vivo using two main components: 454 HD5EU, a newly designed small molecule that serves as a metabolite for the human CYP3A4 Figure 2) , as the tissue 460 expression pattern of the enzyme dictates the site of the small molecule's metabolism and 461 subsequent RNA labeling. To validate the specificity of HD5EU metabolism, we demonstrate that 462 HD5EU is indeed metabolized in a CYP3A4 dependent manner to 5EU-monophosphate. 5EU is 463 then incorporated in place of uridine into transcribing RNA (Figure 2-3) and allows highly 464 selective RNA precipitation and sequencing of labeled RNAs (Sup. Figure 3 and Figure 4a) . 465 Development of new transgenic models would allow for labeling of multiple tissues of choice.
466
Administration of HD5EU allows enrichment for the transcriptional program of proximal renal 467 epithelial cells and hepatocytes in-situ without disruption of the kidney or liver architecture 468 (Figure 4b-g) . In addition, environmentally induced transcriptional reprogramming is evident 469 following labelling (Figure 4h-k) . As opposed to recently described methods [14, 17, 20, 22] and 470 in keeping with the literature where POLI, POLII and POLIII are demonstrated to incorporate 5EU
471
[27], mRNA and small RNAs of various types including rRNA, tRNA and miRNA are found to 472 be labeled and enriched in pulled-down RNA.
473
Critically, and uniquely to iTag-RNA, we are also able to enrich for liver derived plasma ccfRNA 474 following an administration of multiple doses of HD5EU ( Figure 5) . Pulled-down plasma 475 ccfRNAs demonstrate an enrichment for liver derived RNA fragments of protein-coding genes, 476 whilst depleted transcripts demonstrate an enrichment for annotation relating to function and 477 differentiation of the hematopoietic system. Apart from fragments of protein coding genes, liver 478 secreted ccfRNA include various small RNA transcripts such as miRNA, mt-tRNAs and tRNAs.
479
Given the evident enrichment for mitochondrial transcripts following pull-down, our results suggest that hepatocytes are the main source of mitochondrially encoded ccfRNA transcripts in 481 plasma. The functional significance of these tRNA fragments is unclear, but several studies have 482 suggested tRNAs and tRNA fragments can mediate cellular signaling, and that the overall tRNA 483 pool and composition within a cell has functional significance [70] . 484 We continued to explore the possibility that ccfRNAs are taken up by tissues in-vivo to mediate 485 cell-to-cell communication. Focusing on VsWAT we pulled-down and amplified labeled RNA, 486 again following multiple doses of HD5EU (Figure 6a) . The transcripts we identified as labeled in 487 VsWAT demonstrated a greater overlap than expected by chance with labeled plasma ccfRNAs or 488 indeed with labeled transcripts in the liver, supporting their hepatic transcriptional origin. These 489 transcripts including miRNAs and mt-tRNAs (Figure 6b) , with the identified miRNAs implicated 490 in post-transcriptional regulation of proteins involved in lipid, cholesterol and fatty acid pathways.
491
Together our results directly demonstrate for the first time, in-vivo transfer of a large variety of 492 RNAs including miRNAs between hepatocytes and visceral adipose tissue (Figure 6g) , with the 493 identity of transferred RNAs varying following an acute dietary challenge. In light of the observed 494 diversity and scope of RNA transfer between hepatocytes and adipocytes, our results suggest that 495 the pool of small RNAs in a cell in-vivo results from a balance not only between transcription and 496 degradation, but also influx and efflux of small RNAs from the extracellular environment ( Figure   497 6h), with the latter serving as a buffering mechanism for transcriptional and physiological 498 responses in target cells.
499
To date, the majority of potential ccfRNA biomarkers associated with liver pathologies have been 500 miRNAs [71] . Our findings suggest that fragments of protein coding genes together with 501 mitochondrial tRNAs and mitochondria encoded transcripts can also serve as useful biomarkers administration was always carried out at ZG-3 to avoid circadian effects. For blood and organ 521 collection, mice were terminally anesthetized with Ketamin/Xylazine at indicated times following 522 drug administration. Heart puncture was performed to collect blood in EDTA coated syringes.
523
Blood was centrifuged at 4.8K rpm for 10' followed by 12K rpm at 20' and filtration through a Millipore) blocked and blotted using the iBind system (SLF1020, Invitrogen) with primary anti-555 CYP3A4 (MA5-17064, Thermo Fisher), anti-Phospho-p53 S392 (#9281, cell signaling), anti- The authors declare no conflict of interest.
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